Journal of the National Cancer Institute Advance Access originally published online on October 14, 2009
JNCI Journal of the National Cancer Institute 2009 101(21):1444-1445; doi:10.1093/jnci/djp396
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2009.
NEWS |
Capsule Endoscopy To Screen for Colon Cancer Scores Low on Sensitivity, High on Controversy
| The first 10% of the full text of this article appears below. |
Nobody looks forward to a colonoscopy, so a more convenient and noninvasive alternative might boost colorectal cancer screening rates—or so the argument goes. One such alternative is capsule endoscopy. Patients who undergo this procedure swallow a disposable capsule outfitted with a pair of cameras and a wireless transmitter. The device, known as PillCam, shoots roughly 50,000 images during a trip through the colon. Those images are collected by an external recorder and then compressed by software into a diagnostic video.
PillCam's ability to detect colon polyps or cancer doesn't compare well to that of colonoscopy, however. And because of that, its use for cancer screening remains controversial. The method has regulatory approval in countries in Europe, Asia, and Latin America, according to its manufacturer, Given Imaging, in Yokneam, Israel. But health systems don't pay the $1,150 cost even in these countries, said Michael Bretthauer,
Technical Improvements
Colon Cleansing
Noncompliant Population